Scott Dehm, PhD

Administrative support contact for Scott: Irene Schulte

Scott M. Dehm, PhD, is a Professor in the Departments of Laboratory Medicine and Pathology and Urology at the University of Minnesota. He holds the Apogee Enterprises Chair in Cancer Research. Dr. Dehm is a cancer biologist who leads a research team focused on the mechanisms of prostate cancer development and progression, with emphasis on molecular biology of the androgen receptor transcription factor. The major goals of his research are to determine the spectrum of gene rearrangements and splicing alterations in clinical castration-resistant prostate cancer (CRPC), define their biological impact, and establish these alterations as biomarkers of resistance to conventional and next-generation therapies. He is also working on studies to target early steps in therapy-induced prostate cancer lineage plasticity and evaluate novel approaches to overcome androgen receptor aberrations. He is the Co-Director of the Genomics, Cell States, and Signaling (GCSS) Program as well as the Prostate and Urologic Malignancies Translational Working Group at the Masonic Cancer Center. His work is funded by the National Cancer Institute, Department of Defense, and the Prostate Cancer Foundation.